Colgate-Palmolive Slides 1.22% with 315th Volume Rank as Earnings Outlook Weighs

Colgate-Palmolive (CL) fell 1.22% to $85.80 on July 30, with a trading volume of $0.4 billion, ranking 315th in market activity. The stock faces pressure ahead of its Q2 earnings report on August 1, where analysts anticipate a decline in both revenue and earnings per share. The Zacks Consensus Estimate projects $5.1 billion in revenue, reflecting minimal growth year-over-year, while EPS is expected to fall 2.2% to $0.89. Despite past outperformance in earnings surprises, the Zacks model does not currently signal a strong likelihood of a beat, citing mixed signals from its Earnings ESP and a neutral Zacks Rank.

The company’s performance is expected to hinge on productivity initiatives, pricing strategies, and funding-the-growth programs, which have historically supported gross margin expansion. However, headwinds persist from inflationary pressures, currency fluctuations, and softer demand in key regions like Latin America and North America. Management has warned of ongoing challenges, including elevated input costs and competitive dynamics, which could weigh on profitability. While Europe and Pet Nutrition segments may see modest growth, declines in Asia Pacific and North America underscore broader operational risks.

A backtest of a strategy buying the top 500 stocks by daily trading volume and holding for one day showed a 166.71% return from 2022 to July 30, 2025, outperforming the benchmark by 137.53% with a 31.89% compound annual growth rate. This highlights the potential efficacy of volume-driven trading strategies in capturing short-term momentum in high-liquidity stocks.